CRPC
Showing 426 - 444 of 444
Prostatic Tumors Trial in United States (Radium-223 dichloride (BAY88-8223))
No longer available
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Birmingham, Alabama
- +59 more
Jul 11, 2014
Prostate Cancer Trial in Durham, Norfolk (Temsirolimus, Diphenhydramine)
Terminated
- Prostate Cancer
-
Durham, North Carolina
- +1 more
Jan 24, 2014
Prostate Tumors, Prostate Cancer Trial in Edmonton, Vancouver (Abiraterone, Prednisone)
Completed
- Prostate Neoplasms
- Prostate Cancer
-
Edmonton, Alberta, Canada
- +1 more
Jul 14, 2014
Adenocarcinoma of the Prostate, Hormone-refractory Prostate Cancer, Recurrent Prostate Cancer Trial in United States (eribulin
Completed
- Adenocarcinoma of the Prostate
- +3 more
- eribulin mesylate
-
Scottsdale, Arizona
- +146 more
May 21, 2014
Prostate Cancer. Trial in San Antonio (G-202)
Withdrawn
- Prostate Cancer.
-
San Antonio, TexasThe University of Texas Health Science Center
Feb 16, 2014
Prostatic Tumors Trial in Brazil (CABAZITAXEL (XRP6258), DOCETAXEL (XRP6976))
Completed
- Prostatic Neoplasms
- CABAZITAXEL (XRP6258)
- DOCETAXEL (XRP6976)
-
Barretos, Brazil
- +7 more
Dec 23, 2013
Prostate Tumor Trial in Vancouver (Degarelix)
Unknown status
- Prostate Neoplasm
-
Vancouver, British Columbia, CanadaBritish Columbia Cancer Agency
Jun 27, 2012
Radiotherapy vs Observation for CRPC
Unknown status
- Hormone Refractory Prostate Cancer
-
Zhengzhou, Henan, Chinathe first affiliated hospital of Zhengzhou University
May 3, 2012
Prostate Cancer Trial (Metformin HCl, Docetaxel, Prednisone)
Withdrawn
- Prostate Cancer
- Metformin hydrochloride
- +2 more
- (no location specified)
Mar 5, 2013
Soft Tissue Sarcoma Trial in Lyon (LBH589 (Panobinostat®))
Completed
- Soft Tissue Sarcoma
- LBH589 (Panobinostat®)
-
Lyon, FranceCentre Léon Berard
Mar 5, 2013
Prostate Cancer Trial in Amsterdam (GVAX and ipilimumab)
Terminated
- Prostate Cancer
- GVAX and ipilimumab
-
Amsterdam, NetherlandsVU university medical center
Jan 10, 2012
Castration-resistant Prostate Cancer Trial in Seoul (ADT, No ADT)
Unknown status
- Castration-resistant Prostate Cancer
- ADT
- No ADT
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 7, 2011
Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients
Terminated
- Prostatic Neoplasms
-
Bridgewater, New Jersey
- +4 more
Feb 11, 2011